Stocktoria
BALCHEM CORP BCPC
BALCHEM CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $953.7M | $922.4M | $942.4M | $799.0M | $703.6M | $643.7M | $643.7M | $594.8M | $553.2M |
| Gross profit | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M | $223.9M | $211.4M | $204.3M | $189.0M | $180.9M |
| R&D expense | $18.5M | $16.8M | $15.0M | $12.2M | $13.5M | $10.3M | $11.4M | $11.6M | $9.3M | $7.3M |
| Operating income | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M | $111.1M | $102.6M | $107.1M | $96.9M | $90.8M |
| Interest expense | — | — | — | — | — | — | — | — | $7.5M | $7.3M |
| Income tax | $44.2M | $38.0M | $28.7M | $28.4M | $29.1M | $21.8M | $16.8M | $20.5M | -$1.6M | $27.0M |
| Net income | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M | $84.6M | $79.7M | $78.6M | $90.1M | $56.0M |
| EPS (diluted) | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 |
| Operating cash flow | $216.6M | $182.0M | $183.8M | $138.5M | $160.5M | $150.5M | $124.5M | $118.7M | $110.6M | $107.6M |
| Free cash flow | — | — | — | $89.5M | $124.4M | $118.4M | $98.7M | $99.5M | $83.1M | $84.6M |
| Cash & equivalents | $74.6M | $49.5M | $64.4M | $66.6M | $103.2M | $84.6M | $65.7M | $54.3M | $40.4M | $38.6M |
| Inventory | $131.4M | $130.8M | $109.5M | $119.7M | $91.1M | $70.6M | $83.9M | $67.2M | $60.7M | $57.2M |
| Total assets | $1.7B | $1.6B | $1.6B | $1.6B | $1.2B | $1.2B | $1.2B | $981.4M | $963.6M | $948.6M |
| Total liabilities | $428.8M | $425.5M | $543.2M | $686.2M | $322.3M | $337.6M | $412.0M | $289.7M | $346.8M | $427.6M |
| Shareholders' equity | $1.3B | $1.1B | $1.1B | $938.3M | $877.0M | $828.2M | $743.7M | $691.6M | $616.9M | $521.0M |
Growth · year-over-year · Revenue CAGR 7.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +8.8% | +3.4% | -2.1% | +17.9% | +13.6% | +9.3% | +0.0% | +8.2% | +7.5% | +0.1% |
| Net income growth | +20.5% | +18.4% | +3.0% | +9.6% | +13.6% | +6.2% | +1.4% | -12.8% | +60.9% | -6.3% |
| EPS growth | +20.9% | +17.3% | +3.1% | +10.5% | +13.1% | +6.1% | +1.2% | -13.3% | +59.4% | -7.4% |
| Free cash flow growth | — | — | — | -28.1% | +5.0% | +20.0% | -0.9% | +19.8% | -1.8% | +35.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.